Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study). [electronic resource]
Producer: 20021002Description: 526-9 p. digitalISSN:- 0002-9149
- Abciximab
- Aged
- Angioplasty, Balloon, Coronary -- economics
- Antibodies, Monoclonal -- economics
- Cardiac Catheterization -- economics
- Cardiomyopathies -- pathology
- Combined Modality Therapy
- Creatine Kinase -- blood
- Creatine Kinase, MB Form
- Eptifibatide
- Female
- Humans
- Immunoglobulin Fab Fragments -- economics
- Incidence
- Isoenzymes -- blood
- Male
- Middle Aged
- Myocardial Infarction -- epidemiology
- Necrosis
- Peptides -- economics
- Pilot Projects
- Platelet Aggregation Inhibitors -- economics
- Platelet Glycoprotein GPIIb-IIIa Complex -- economics
- Predictive Value of Tests
- Stroke Volume -- physiology
- Tirofiban
- Treatment Outcome
- Troponin I -- blood
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.